Kriti Nutrients Ltd

Dematerialisation processing and listing

• Dematerialisation requests were processed (accepted/rejected) by the registrar and share transfer agent to the depositories.
• Dematerialised securities were listed on the stock exchanges where the earlier issued securities are listed.
• Physical certificates for dematerialisation were mutilated and cancelled; the depository's name substituted as registered owner within 15 days.

Kriti Nutrients Ltd — Closure of Trading Window

Compliance Update

• Heading of accompanying statement is 'STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS'.
• Requests NSE to drop the observation and take no further action.

AGM Details

• Date and mode: 12 August 2026, VC/OAVM; no physical attendance.
• Quorum: 30; 49 members attended via video conference.
• Cut-off date: 5 August 2026; members on cut-off: 19,740.
• Remote voting: 9–11 August 2026; results declared within 2 days.
• Meeting concluded at 5:01 PM.

Key Resolutions

• Ordinary 1: Adoption of audited standalone and consolidated financial statements.
• Ordinary 2: Interim dividend of Rs 3.00 per share confirmed.
• Ordinary 3: Re-appointment of Saurabh Singh Mehta by rotation.
• Ordinary 4: Re-appointment of M/s M Mehta & Co as Statutory Auditors.
• Ordinary 5: Ratification of Cost Auditors’ remuneration for 2026-27.
• Special 6: Remuneration revision for Saurabh Mehta as WTD/JMD; cap may exceed 5%.
• Special 7: Reappointment of Shiv Singh Mehta as Chairman & MD for 2027–2030.
• Special 8: Reappointment of Saurabh Mehta as WTD/JMD for 2027–2030; remuneration terms.

Voting Results

• All resolutions passed by requisite majority; Scrutiniser’s report dated 13 August 2026.
• Res 1: Passed; ordinary resolution.
• Res 2: Passed; interim dividend approved.
• Res 3: Passed; re-appointment by rotation.
• Res 4: Passed; statutory auditors re-appointed.
• Res 5: Passed; cost auditors’ remuneration ratified.
• Res 6: Passed; special resolution on remuneration above cap.
• Res 7: Passed; special resolution for MD appointment.
• Res 8: Passed; special resolution for WTD/JMD appointment.

Dividend

• Interim dividend of Rs 3.00 per equity share approved (for FY 2025-26).

Director Changes

• Saurabh Singh Mehta re-appointed by rotation.
• Shiv Singh Mehta re-appointed as Chairman and MD for 2027–2030.
• Saurabh Singh Mehta re-appointed as WTD/JMD for 2027–2030.

Auditor Appointments

• M/s Mehta & Co re-appointed as Statutory Auditors for 2026-27 to 2031.
• Remuneration for Cost Auditors Rs 35,000 ratified.

Related Party Transactions

• No material related party transactions disclosed.

Other Material Approvals

• Remuneration revisions for directors may exceed 5% of net profits; Board discretion granted.

Statutory Auditor Reappointment

• Reappointment of M/s M. Mehta & Company as Statutory Auditors.
• Term: five years from 12 Aug 2026 to AGM 2031.
• Profile: Indore-based CA firm with extensive statutory audits.
• Reason: Reappointment.

Chairman & Managing Director Reappointment

• Reappointment of Shiv Singh Mehta as Chairman and Managing Director.
• Date of appointment: 12 August 2026.
• Term: three years from 12 Jan 2027 to 11 Jan 2030.
• Profile: BE Electrical Eng; MBA; founder and promoter.
• Relationships: Relative of wife Purnima Mehta and son Saurabh Mehta.
• Not debarred by SEBI.

Joint Managing Director Reappointment

• Reappointment of Saurabh Singh Mehta as Whole Time Director (Joint Managing Director).
• Date of appointment: 12 August 2026.
• Term: three years from 1 Aug 2027 to 31 Jul 2030.
• Profile: BE Computer Science; MBA in Family Business; 13 years' experience.
• Relationships: Son of Shiv Singh Mehta and Purnima Mehta.
• Not debarred by SEBI.

AGM outcomes

• Adoption of Audited standalone and consolidated financial statements for year ended 31 March 2026.
• Interim dividend Rs 3.00 per share on 5,01,03,520 equity shares.
• Re-appointment of Saurabh Singh Mehta who retires by rotation.
• Re-appointment of M Mehta & Company as statutory auditors.
• Ratification of remuneration payable to Dhananjay V. Joshi & Associates for 2026-27.
• Revision in remuneration of Saurabh Singh Mehta as Whole-time Director and Joint MD.
• Reappointment and remuneration of Shiv Singh Mehta as Chairman and Managing Director.
• Reappointment and remuneration of Saurabh Singh Mehta as WTD designated as Joint MD.

AGM details

• AGM held on 12 August 2026 at 4:30 PM via video conferencing.
• Venue deemed at Indore address; meeting conducted online.
• Promoter group and public attendees participated via VC.

Resolutions

• Resolution 1: Adoption of financial statements and directors' and auditors' reports.
• Resolution 2: Interim dividend for FY 2025-26 approved.
• Resolution 3: Re-appointment of Mr. Saurabh Singh Mehta as Director.
• Resolution 4: Re-appointment of statutory auditors M/s Mehta & Co.
• Resolution 5: Ratification of remuneration for Cost Auditor FY 2026-27.
• Resolution 6: Special: Re-appointment of Whole-time Director and remuneration.
• Resolution 7: Special: Re-appointment of Chairman and Managing Director; remuneration fixed.

Voting results

• All ordinary resolutions passed; strong promoter support.
• Resolution 6 showed public opposition around 1.6%.
• Resolution 7 passed with high overall support; minimal public opposition.

Dividend

• Interim dividend for FY 2025-26 approved; per-share amount not disclosed.

Directors

• Mr. Saurabh Singh Mehta re-appointed as Director.

Auditors

• Statutory auditors re-appointed: M/s Mehta & Co.

Other material approvals

• Remuneration approvals for senior managerial appointments as part of AGM.

AGM Proceedings and Key Outcomes

• 30th AGM held Aug 12, 2026 via VC/OAVM; proceedings submitted per SEBI LODR.
• E-voting completed Aug 11; results to be communicated within two working days after Scrutinizer's Report.
• Ordinary business: adoption of standalone and consolidated financial statements for year ended 31 March 2026.
• Interim dividend of Rs 3.00 per share approved as final for FY25-26; total Rs 1503.11 Lakhs.
• Saurabh Singh Mehta re-appointed as Joint Managing Director for 1 Aug 2027 to 31 Jul 2030.
• Shiv Singh Mehta re-appointed as Chairman and Managing Director for 12 January 2027 to 11 January 2030.
• Statutory Auditor M/s M Mehta & Company re-appointed for the second consecutive five-year term (2026-2031).
• Cost Auditor remuneration of Rs 35,000 plus taxes approved for FY2026-27.
• Remuneration framework approvals for top executives were approved per board.